Sectors

The cancer immunotherapy developer's latest round included pharmaceutical producers and co-founders Juno Therapeutics and WuXi AppTec.

The CNS disorder drug developer has launched with $76m from investors including Biogen, Bristol Myers Squibb and Pfizer Ventures.

GV co-led a series C round for the healthcare collaboration service together with F-Prime Capital, Andreessen Horowitz and Transformation Capital, taking its overall funding past $101m.

The Legend Capital-backed auto parts e-commerce marketplace boosted its total funding to $110m in a $56.6m round led by Huaxing Growth Capital Fund.

Stanford’s lysosome protein degradation spinout Lycia emerged with $50m of capital from Versant Ventures to develop a portfolio of drug candidates.

The owner of online travel platforms Ctrip, Skyscanner and Qunar, has committed $14.1m to its in-house investment fund, Xiecheng Entrepreneurship Investment Company.

Existing backer GV returned to take part in a $100m round for the Stanford spinout that also attracted new investor Regeneron Pharmaceuticals.

Siemens and Scania-backed Sennder has merged with fellow on-demand logistics provider Everoad to seize a larger chunk of the European marketplace.

The bank digitisation software provider Nymbus has now raised more than $45m in total, Vensure Enterprise co-leading its latest round.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Varian Medical Systems and Johnson & Johnson Innovation – JJDC have returned for the series C-1 round having backed the U-M spinout's series C last year.